Robeco Institutional Asset Management B.V. Dynavax Technologies Corp Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $30,394 - $34,783	2,322 New	2,322 $32,000
Q4 2023 Feb 08, 2024	BUY	$13.09 - $14.98 $0 - $0	0 New	0 $2.32 Million

Others Institutions Holding DVAX

# of Institutions

276

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

Black Rock Inc. New York, NY

21.9M
Shares

$277 Million
0.01% of portfolio
Deep Track Capital, LP Greenwich, CT

12.5M
Shares

$159 Million
5.15% of portfolio
Vanguard Group Inc Valley Forge, PA

9.22M
Shares

$117 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

8.33M
Shares

$105 Million
7.62% of portfolio
State Street Corp Boston, MA

7.69M
Shares

$97.4 Million
0.0% of portfolio

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account